Rimar Doron, Kruzel-Davila Eti, Dori Guy, Baron Elzbieta, Bitterman Haim
The Ruth and Bruce Rappaport Faculty of Medicine, Department of Medicine, Carmel Medical Center, Technion-Israel Institute of Technology, Haifa, Israel.
J Gen Intern Med. 2007 Apr;22(4):549-52. doi: 10.1007/s11606-007-0131-6.
Hepatic encephalopathy and myxedema coma share clinical features: coma, ascites, anemia, impaired liver functions, and a "metabolic" electroencephalogram (EEG). Hyperammonemia, a hallmark of hepatic encephalopathy, has also been described in hypothyroidism. Differentiation between the 2 conditions, recognition of their possible coexistence, and the consequent therapeutic implications are of utmost importance. We describe a case of an 82-year-old woman with a history of mild chronic liver disease who presented with hyperammonemic coma unresponsive to conventional therapy. Further investigation disclosed severe hypothyroidism. Thyroid hormone replacement resulted in gain of consciousness and normalization of hyperammonemia. In patients with an elevated ammonia level, altered mental status, and liver disease, who do not have a clear inciting event for liver disease decompensation, overwhelming evidence of hepatic decompensation, or who do not respond to appropriate therapy for hepatic encephalopathy, hypothyroidism should be considered and evaluated.
昏迷、腹水、贫血、肝功能受损以及“代谢性”脑电图(EEG)。高氨血症是肝性脑病的一个标志,在甲状腺功能减退症中也有描述。区分这两种情况、认识到它们可能并存以及由此产生的治疗意义至关重要。我们描述了一例82岁女性病例,她有轻度慢性肝病病史,出现了对传统治疗无反应的高氨血症昏迷。进一步检查发现严重甲状腺功能减退。甲状腺激素替代治疗后意识恢复,高氨血症恢复正常。对于氨水平升高、精神状态改变且患有肝病的患者,如果没有明确的肝病失代偿诱发事件、没有压倒性的肝失代偿证据,或者对肝性脑病的适当治疗无反应,应考虑并评估甲状腺功能减退症。